a public good project by the
Synthesis
Company
of California

© 2026

James M. Nelson | doi.page

0 works0 citations0 h-index

James M. Nelson

University of Georgia(US)University of Louisiana at Lafayette(US)

Publications by Year

Research Areas

Religion, Spirituality, and Psychology, HER2/EGFR in Cancer Research, Organometallic Complex Synthesis and Catalysis, Synthesis and characterization of novel inorganic/organometallic compounds, Flame retardant materials and properties

Most-Cited Works

→ A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase(1994)802 cited
→ PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib(2007)717 cited
→ Psychology, Religion, and Spirituality(2009)432 cited
→ Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor(1998)417 cited
→ Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor(2008)221 cited
→ Transition Metal-Catalyzed Formation of Phosphorus−Boron Bonds: A New Route to Phosphinoborane Rings, Chains, and Macromolecules(2000)216 cited

→ “Living” Cationic Polymerization of Phosphoranimines as an Ambient Temperature Route to Polyphosphazenes with Controlled Molecular Weights(1996)199 cited

→ Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor(1999)178 cited

→ Organometallic Ferrocenyl Polymers Displaying Tunable Cooperative Interactions between Transition Metal Centers(1993)173 cited

→ Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor(1996)149 cited